JACI: In Practice Editor Michael Schatz describes the September issue, the theme of which is “Biologics”. Theme topics covered include the use of biologics for asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and hypereosinophilic syndromes. Dr. Schatz then presents the Highlights of the Original Articles in the issue, which are on the topics of Biologics, Asthma, Dermatitis, Drug Allergy, Eosinophilic Disorders, Food Allergy, Immunodeficiency, Immunotherapy, Insect Sting Allergy, and Urticaria.

August 2023 Podcast Description

JACI: In Practice Editor Dave Khan describes the August issue, the theme of which is “Focus on Urticaria and Angioedema”. Theme topics covered include masqueraders and misdiagnoses, genetic variants and biomarkers, autoreactivity and autoimmunity, treatment beyond antihistamines and biologics, cold urticaria, angioedema with normal complement studies, and hereditary angioedema. Dr. Khan then presents the Highlights of the Original Articles in the issue, which are on the topics of Urticaria and Angioedema, Asthma, Dermatitis, Eosinophilic Disorders, Food Allergy, Immunodeficiency, Mast Cell Disorders, Rhinitis and Sinusitis, and Topics in Quality Improvement and Patient Safety.

JACI: In Practice Editor Scott Sicherer describes the July issue, the theme of which is “Anaphylaxis”. Theme topics covered include the disease spectrum of anaphylaxis disorders, extrinsic and intrinsic modulators, vaccine-related allergy and anaphylaxis, venom anaphylaxis, refractory anaphylaxis, and novel therapies. Dr. Sicherer then presents the Highlights of the Original Articles in the issue, which are on the topics of Anaphylaxis, Asthma, Drug Allergy, and Food Allergy. 

JACI: In Practice Deputy Editor Robert Zeiger describes the June issue, the theme of which is “Immunodeficiency”. Theme topics include the genetics, diagnosis, management, and complications of various types of inborn errors of immunity and related disorders. Dr. Zeiger then presents the Highlights of the Original Articles in the issue, which are on the topics of Immunodeficiency, Allergic Bronchopulmonary Aspergillosis, Asthma, Drug Allergy, and Food Allergy. 

JACI: In Practice Editor Scott Sicherer describes the May issue, the theme of which is “Advances in Atopic Dermatitis”. Theme topics covered include Targeting Skin Barrier Function, A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors, Biologic Versus Small Molecule Therapy, Skin Antiseptics, and Managing Atopic Dermatitis in Patients With Skin of Color. Dr. Sicherer then presents the Highlights of the Original Articles in the issue, which are on the topics of Atopic Dermatitis, Asthma, Drug Allergy, Food Allergy, Immunotherapy, and Mast Cell Disorders.

JACI: In Practice Deputy Editor Scott Sicherer describes the April issue, the theme of which is “Difficult Decisions in Food Allergy”. Theme topics covered include precautionary allergen labeling, oral food challenges, immunotherapy, and epinephrine treatment. Dr. Sicherer then presents the Highlights of the Original Articles in the issue, which are on the topics of Food Allergy, Anaphylaxis, Asthma, Drug Allergy, Hereditary Angioedema, Immunodeficiency, Rhinitis, and Urticaria.

JACI: In Practice Editor-in-Chief Michael Schatz describes the March 2023 issue, the theme of which is “Hot Topics in Asthma”. Theme topics covered include health disparities in asthma, the role of lung function in the development of childhood asthma, mechanistic studies that help to define clinical asthma phenotypes and endotypes in children, and factors to consider when prescribing biologics to children with asthma. In addition, three new asthma management paradigms are discussed: a proactive predict and prevent approach, treatable traits, and using inhaled corticosteroids as part of rescue therapy. Dr. Schatz then presents the Highlights of the Original Articles in the issue, which are on the topics of asthma, allergic bronchopulmonary aspergillosis, mast cell disorders, rhinitis and sinusitis, and urticaria and angioedema

JACI: In Practice Associate Editor David Khan describes the February 2023 issue, the theme of which is “Drug Allergy”. Theme topics covered include Practice Parameter updates; placebo, nocebo and patient reported outcome measures in drug allergy; perioperative hypersensitivity; and various aspects of penicillin allergy. Dr. Khan then presents the Highlights of the Original Articles in the issue, which are on the topics of Drug Allergy, Asthma, Food Allergy, Mast Cell Disorders, Rhinitis and Sinusitis, and Urticaria and Angioedema.

JACI: In Practice Editor-in-Chief Michael Schatz describes the January issue, which is a special issue celebrating the first 10 years of publication of the Journal, 2013-2022. The issue contains articles describing the most important advances of the past decade in the spectrum of illnesses covered in the Journal pages over the past 10 years. The conditions covered in these state-of-the-art reviews include asthma (diagnosis, and management in children and adults), allergic and non-allergic rhinitis (along with immunotherapy), chronic rhinosinusitis, anaphylaxis, atopic dermatitis, food allergy and eosinophilic gastrointestinal diseases, drug hypersensitivity, urticaria and angioedema, and immunodeficiency.  Dr. Schatz then presents the Highlights of the Original Articles in the issue, which are on the topics of asthma, dermatitis, food allergy, immunodeficiency, and rhinitis and sinusitis.

Read the issue:   https://www.jaci-inpractice.org/issue/S2213-2198(22)X0002-0
Access JACI: In Practice’s entire library: https://www.jaci-inpractice.org

JACI: In Practice Editor-in-Chief Michael Schatz describes the December issue, the theme of which is “Adverse Effects of Drugs Used in Allergy and Immunology Practice”. Theme topics covered include an overview of the FDA labeling and approval process, FDA boxed warnings and the off-label use of medications, the safety of commonly used allergy and asthma medications in children, safety considerations for natural products commonly used by patients with allergic disease, and safety issues regarding medications for refractory chromic urticaria, biologics, proton pump inhibitors, and diphenhydramine. Dr. Schatz then presents the Highlights of the Original Articles in the issue, which are on the topics of anaphylaxis, asthma, dermatitis, drug allergy, food allergy, and urticaria and angioedema.